Skip to content
Trial Eligibility
Menu

Cannabis for Palliative Care in Cancer

NCT06266611

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Many cancer patients suffer from pain, sleep, and mood problems and are using cannabis to relieve these symptoms. Cannabis may provide such relief but may also produce negative side effects including cognitive impairment, an especially problematic issue for cancer patients, indicating more research on cannabis use in the cancer context is required.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Sleep
  • Anxiety
  • Depression
  • Pain

Eligibility basics and study details

Study type
Interventional
Phase
Phase 2
Ages
25 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
University of Colorado, Boulder
Last updated on ClinicalTrials.gov
August 1, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Colorado · 1

  • Anschutz Health Sciences Building · Aurora, CO

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.